Volume 11 • Issue 3 • March 2017
ISSN 1814 3601
Figure 1. Distribution of confirmed measles cases with rash onset 1–28 February 2017, WHO Western Pacific Region
Legend: No confirmed case With confirmed case No case based data Dots are placed at random within the corresponding district, and might not reflect the exact location of the case
DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved *Map of Australia is from the Australian Bureau of Statistics
Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 March 2017
Table 1. Confirmed measles cases by month of rash onset, March 2016–February 2017, WHO Western Pacific Region Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region "-" No data
2016 Mar 16 0 0 4663 0 0 2 0 200 850 2 0 20 2 10 4 1 5770 Apr 10 0 0 5247 1 0 0 0 187 598 20 0 7 1 18 3 1 6093 May 5 0 2 3923 2 0 3 0 154 378 37 0 6 0 31 3 1 4545 Jun 4 0 4 2619 2 0 3 0 112 79 29 0 3 0 6 3 1 2865 Jul 6 0 5 1695 0 0 5 0 70 22 5 0 3 0 3 6 0 1820 Aug 1 1 11 866 0 0 76 0 105 4 3 0 4 1 8 3 0 1083 Sep 7 0 1 350 1 0 43 0 57 2 1 0 6 8 7 1 0 484 Oct 7 0 9 208 0 0 10 0 78 2 1 0 8 4 11 2 0 340 Nov 6 0 12 222 0 0 2 0 58 2 0 0 4 0 24 0 0 330 Dec 16 0 10 531 3 0 5 8 64 4 0 0 3 0 16 0 0 660 Jan
2017 Feb 9 0 4 306 1 0 15 0 70 2 6 0 1 9 0 423 4 0 4 437 1 0 24 0 36 1 2 0 0 7 0 516
Source: Case based and aggregate data reports to the Western Pacific Regional Office by 20 March 2017
Figure 2. Confirmed measles cases by month of rash onset, WHO Western Pacific Region, 2012–2017 as of 20 March 2017 16 000
14 000
12 000
10 000 Number of measles cases
8 000
6 000
4 000
2 000
Mar
Mar
Mar
Mar
Aug
Aug
Aug
Aug
Mar
Aug
Jul
Jul
Jul
Jul
Nov
Nov
Nov
Nov
Jul
May
May
May
May
May
Nov
Jun
Jun
Jun
Jun
Jun
Jan
Jan
Jan
Jan
Jan
Apr
Apr
Apr
Apr
Feb
Feb
Feb
Feb
Feb
Apr
Jan
Dec
Dec
Dec
Dec
2012
2013
2014
2015
2016
Dec
Sep
Sep
Sep
Sep
Sep
2017
China
Philippines
Viet Nam
Malaysia
Papua New Guinea
Others
Source: Measles and rubella monthly country reports to WHO by 20 March 2017 Includes laboratory confirmed, epi-linked and clinically confirmed cases for 2012
Table 2. Status of measles verification, WHO Western Pacific Region 2016 Country/area Year No. of cases Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Total 2014 2015 2015 2016 2014 2015 2014 99 1 56 23 960 9 0 152 8 1 569 3 587 104 0 74 18 140 36 5 29 818 Imported 30 1 0 0 1 27 0 4 0 0 1 9 16 0 0 89 Source of infection Importrelated 18 0 0 0 0 97 0 0 2 392 0 0 9 90 0 0 2 606 Unknown / not reported 50 0 56 23 960 8 28 8 437 0 104 53 0 34 36 5 24 779 % of c ases w ith
2017 No. of confirmed cases 13 0 9 743 2 0 39 0 106 3 8 0 1 16 0 940 No measles cases ≥80% 60–79% <60% Imported 7 0 0 1 7 2 0 0 1 5 23 Source of infection Importrelated 5 0 0 0 8 0 0 0 0 7 20 Unknown / not reported 1 9 743 1 24 44 3 8 0 4 837 % of c ases w ith know n
verified confirmed
Endemic sourc e of infec tion
know n
Endemic sourc e of infec tion
0 0 0 0 0 0 0 1 052 1 196 0 20 0 0 0 0 2 268
48.5% 100.0% 0.0% 0.0% 11.1% 81.6% 0.0% 67.3% 100.0% 0.0% 28.4% 100.0% 75.7% 0.0% 0.0% 16.6% Blue Green Yellow Red
0 0 0 0 0 60 0 0 0 0 60
92.3% 0.0% 0.0% 50.0% 38.5% 58.5% 0.0% 0.0% 100.0% 75.0% 11.0%
Source: Measles and rubella monthly country reports to WHO by 20 March 2017
2
Feb
Oct
Oct
Oct
Oct
Oct
0
Table 3. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2013 —2017 as of 20 March 2017 2013 Measles incidence 1
2014 Measles incidence 1
2015 Measles incidence 1
2016 Measles incidence per 1 million pop. 3.3 9.0 0.0 29.5 1.6 0.0 0.3 8.0 43.3 566.4 2.9 6.9 6.8 0.1 7.7 3.1 6.1 24.2 99 1 56 23 960 9 0 152 8 1 569 3 587 104 0 74 18 140 36 5 29 818 4.1 2.3 3.5 17.3 1.2 0.0 1.2 1.2 51.0 1193.1 22.8 0.0 0.7 0.4 24.6 0.4 1.5 16.0 Green Yellow Red
2017 Confirmed measles cases Population (in millions) 2
Rash onset of Deaths due to last confirmed measles case 24-Feb-17 7-Aug-16 2-Mar-17 28-Feb-17 15-Feb-17 3-Jun-14 26-Feb-17 27-Dec-16 22-Feb-17 13-Feb-17 14-Feb-17 21-Sep-15 10-Dec-16 9-Jan-17 21-Feb-17 22-Oct-16 9-Jun-16
Country/area
Total confirmed
per 1 million pop.
Total confirmed
per 1 million pop.
Total confirmed
per 1 million pop.
Total confirmed
Suspected measles cases 3
Pending classification
Discarded Compatible cases 3
Annualized Lab Epi-linked
cases
Total measles confirmed incidence per measles 1 million pop. 13 9 743 2 0 39 0 106 3 8 0 1 16 0 940 3.2 3.4 3.2 1.6 0.0 1.9 0.0 20.4 5.9 10.4 0.0 0.1 16.6 0.0 3.0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 1 2 3 4
154 0 0 26912 34 3 141 68 177 0 9 7 3777 107 56 895 4
6.6 0.0 0.0 19.8 4.7 5.2 1.1 10.5 5.9 0.0 2.0 1.0 38.5 2.2 10.6 9.9 0.0 17.7
340 0 0 48 123 46 1 434 70 213 0 263 2 589 23 708 442 134 12 223 273 88 859
14.5 0.0 0.0 35.3 6.3 1.7 3.4 10.7 7.0 0.0 57.7 345.9 237.6 9.0 25.1 133.5 83.4 48.3
74 4 0 41 217 12 0 32 56 1 302 1 617 13 53 688 7 39 291 20 45 425
24.6 0.4 16.1 1388.2 7.4 0.6 126.0 7.0 31.2 3.1 4.6 7.9 103.8 50.7 5.8 95.4 3.3 1876.2
NA
0 0 347 0 0 1 106 121 0 3 0 0 0 0 578
0 128 2 205 3 1 49 3 738 48 0 1 34 15 21 3 246
0 0 261 0 0 1 0 14 0 0 0 0 2 0 278
12 9 736 2 0 37 0 106 3 6 0 1 16 0 928
1 0 7 0 0 2 0 0 0 2 0 0 0 0 12
0 137 3 556 5 1 90 109 987 51 11 1 Not available
38 34 Not available
0 32 340
21 5 041
Includes laboratory confirmed and epi-linked confirmed cases United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects. Australia reports confirmed cases only. Classification is provisional based on laboratory data only.
<1 confirmed measles case / 1 000 000 population 1–9.9 confirmed measles case / 1 000 000 population >= 10 confirmed cases / 1 000 000 population
3
Table 4. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2016 —2017 as of 20 March 2017 2016 Discarded non-measles Second level units with ≥ 2 discarded cases per 100 000 pop [annualized]1 Suspected cases with adequate investigation Suspected cases with adequate specimens for laboratory confirmation 2
2017 Annualized discarded non-measles rate per 100 000 pop Second level units with ≥ 2 discarded cases per 100 000 pop [annualized]1 Suspected cases with adequate investigation Suspected cases with adequate specimens for laboratory confirmation 2
Country/area
rate per 100 000 pop
≥2
≥ 80% Insufficient data Not applicable
≥ 80% Insufficient data
≥ 80% Insufficient data
≥2 Insufficient data
≥ 80% Insufficient data Not applicable
≥ 80% Insufficient data Not applicable
≥ 80% Insufficient data Not applicable
Australia 3 Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 1
Insufficient data
2.8 4.2 3.2 2.5 2.0 0.7 7.3 16.1 46.4 1.1 0.6 1.5 0.6 4
100.0% 88.3% 97.1% 97.9% 100.0% Insufficient data
100.0% 99.0% 87.9% 99.5% 100.0% Insufficient data
0.0 9.6 1.9 0.0 2.0 0.5 0.5 28.4 18.9 0.0 0.2 Not available
72.0% 77.4% Not applicable Not applicable
8.0% 3.2% Not applicable Not applicable
94.9% 91.3% 80.0% 100.0% Insufficient data
99.3% 81.3% 80.0% 100.0% Insufficient data
4.3% 70.6% 93.8% 95.5% Insufficient data
0.0% 5.9% 93.8% 13.6% Insufficient data
98.6% 79.7% 8.0% Insufficient data
47.6% 88.8% 14.4% Insufficient data
95.4% 78.5% 90.2% Insufficient data
96.3% 86.4% 86.3% Insufficient data
10.0% 17.6% 0.0% Not applicable
65.3% 57.3% 92.1% 85.1% 57.1% 0.0% 70.7% Green Yellow Red
89.8% 70.2% 79.9% 51.8% 78.1% 82.4% 67.7% Reached or surpassed target
0.0% Not available
0.0% Not applicable
0.0% Not applicable
0.8 3.1 Not available
0.0% Not applicable Not available
86.8% 85.3% Not applicable
92.1% 55.9% Not applicable
1.6 1.2 8.3 3.0
22.2% 13.0% 38.5%
7.7 2.1
8.7% 8.1%
0.0% 88.4%
90.5% 83.2%
This indicator is not applicable for countries which have no second-level administrative units 2 Adequate specimen defined as blood specimen collected within 28 days of rash onset or other specimen (throat swab, nasopharyngeal swab, cerebrospinal fluid, urine) collected within 5 days of rash onset; excludes epidemiologically-linked cases. 3 Reports only confirmed cases.
Nearly reached target: 1.00–1.99 for non- measles suspected case rate; 10.1–25% for percent clinically confirmed cases; 60–79% for other indicators Substantially below target
4 2
Table 5. Rubella case classification and incidence by country and area, WHO Western Pacific Region, 2014 –2017 as of 20 March 2017 2014 2015 2016 2017 Confirmed rubella cases Annualized Congenital Total rubella rubella Epi-linked confirmed incidence per syndrome 1 million pop. 0 0 0 0 0 0 0 0 0 0 0 0 1 123 0 0 2 0 7 3 0 0 0 0 0 1 137 0.0 0.4 0.5 0.0 0.0 0.1 0.0 1.3 5.9 0.0 0.0 0.0 0.0 0.0 1.8 0.4 -
Country/area
Population Rubella Rubella Rubella Total Total Total Investigated Pending Discarded Compatible (in incidence per incidence per incidence per confirmed confirmed confirmed cases cases 1 rubella cases classification 1 million pop. 1 million pop. 1 million pop. millions) 0 30 11 887 1 0 18 226 0 343 2 0 50 2
Lab
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 1 2
0.0 2.0 8.7 0.1 0.0 2.8 7.5 0.0 3.4 0.0 0.0 0.5 1.2 6.8
0 18 8 245 7 2 2 24 34 28 4 154 2 1 862 0 9 383
0.0 1.1 5.9 0.9 3.5 0.0 3.4 1.1 9.8 0.5 1.5 0.0 0.2 9.2 0.0 5.0
0 4 4 476 3 1 3 21 67 17 2 165 3 0 307 1 5 070
0.0 0.3 3.2 0.4 1.7 0.0 3.0 2.2 5.7 0.3 1.6 0.1 0.0 3.3 0.3 2.7 Green Yellow Red Gray
24.64 0.43 16.08 1 388.23 7.40 0.61 126.05 7.04 31.16 3.05 4.60 7.93 103.80 50.70 5.78 95.41 3.28 1 876.21
1 137 3 556 0 1 5 109 987 42 1 35 21 4 895
0 0 0 0 106 121 0 0 0 0 227
1 136 1 3 3 859 39 1 35 20 1 098
0 0 0 0 0 0 0 0 0 0 0
0 1 0 2 0 7 3 0 0 1 14
4 12 561
United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects. Classification is provisional based on laboratory data only.
<1 confirmed measles case / 1 000 000 population 1–9.9 confirmed measles case / 1 000 000 population >= 10 confirmed cases / 1 000 000 population No data
"-" No data
5
Table 6A. Measles and rubella laboratory testing, WHO Western Pacific Region, 2016 as of 20 February 2017 Measles Measles and rubella Serum Country/area Laboratory Total Total number number of of samples samples received tested 92 16 719 600 46 1 585 254 8 579 10 031 842 40 1 612 633 813 332 870 183 77 243 15 27 582
Serology Blood DBS samples Samples Measles tested for Measles IgM (+) IgM measles IgM equiv No. 22 13 596 538 46 206 254 6 256 9 749 221 40 1 524 400 243 313 865 182 77 233 15 21 793
Total number of cases tested 67 13 719 509 46 802 254 6 593 9 996 757 40 1 610 530 724 318 868 183 77 243 15 24 364
No. 14 1 54 9 3 44 2 1 620 4 969 22 0 36 51 25 1 39 2 0 5 0 6 897
% 63.6 7.7 9.1 1.7 6.5 21.4 0.8 25.9 51.0 10.0 2.4 12.8 10.3 0.3 4.5 1.1 2.1 0.0 31. 6
No. 4 1 0 16 2 34 4 180 981 10 0 31 33 0 1 20 1 0 4 0 1 322
No. received 0 0 123 0 0 0 0 0 0 0 0 51 0 0 0 0 0 0 9 15 198
No. (+) 2 5 0 0 7
Rubella Virus detection Serum and blood (includes DBS) Measles Virus Measles isolation/ Reverse Total % of Samples Rubella detection Transcription- number of samples tested for Rubella IgM (+) IgM (swab, urine and Polymerase Chain lab with rubella IgM equiv others) Reaction confirmed results ≤4 No. of No. of cases No. of days No. No. % No. samples samples No. (+) isolates tested tested 72.7 92.3 80.9 89.0 93.0 100.0 80.7 93.6 99.8 98.2 7.5 98.9 82.9 100.0 96.1 85.2 51.1 20.8 95.1
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, M acao SAR Japan Lao People's Democratic Republic M alaysia M ongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Vanuatu Total "-" No data
VIDRL DLS NIPH CCDC PHLC PHL NIID NCLE NPHL NCCD CHL CPHL RITM KCDC SGH NIHE PI PI IHE FCCDC FCCDC
92 16 719 600 46 1 398 254 6 593 10 031 842 40 1 612 633 813 332 870 183 77 243 15 25 409
0 0 0 5 0 0 0 1 264 1 1 0 62 0 186 10 5 0 0 0 0 1 534
4 122 0 0 0 6 0 0 132
66 1 0 64 1 669 0 0 286 590 0 62 222 0 19 5 1 0 0 0 1 986
60 1 20 0 146 142 68 0 17 0 0 0 454
58 1 44 12 3 156 0 1 662 5 076 79 0 40 55 25 1 39 2 0 5 0 7 258
7 13 719 535 46 10 254 4 513 6 506 157 40 1 576 244 347 313 865 182 77 243 15 16 662
2 0 4 3 4 1 8 108 31 1 1 110 25 2 31 384 10 0 1 0 726
28.6 0.0 0.6 0.6 8.7 3.1 2.4 0.6 2.5 7.0 10.2 0.6 9.9 44.4 5.5 0.0 0.4 0.0 4.4
0 0 0 3 1 0 9 53 15 0 2 62 18 0 15 24 3 1 0 1 207
6
Table 6B. Measles and rubella laboratory testing, WHO Western Pacific Region, 2017 as of 20 March 2017 Measles Measles and rubella Serum Country/area Laboratory Total Total number number of of samples samples received tested 12 1 137 46 6 170 109 1 332 86 75 4 370 81 51 12 45 3 0 23 2 563
Serology Blood DBS samples Samples Measles tested for Measles IgM (+) IgM measles IgM equiv No. 3 1 113 38 6 21 109 1 018 82 22 4 355 51 8 12 45 3 0 22 1 913
Total number of cases tested 8 1 137 39 6 87 109 1 058 82 68 4 370 62 50 12 45 3 0 22 2 163
No. 2 0 9 2 0 10 0 143 0 2 0 4 5 2 0 0 0 0 179
% 66.7 0.0 8.0 5.3 0.0 47.6 0.0 14.0 0.0 9.1 1.1 9.8 25.0 0.0 0.0 0.0 9. 4
No. 1 1 0 1 0 2 0 24 3 2 0 6 3 0 1 1 0 0 45
No. received 0 0 24 0 0 0 0 0 0 0 0 11 0 0 0 0 0 0 1 36
No. (+) 0 1 0 1
Rubella Virus detection Serum and blood (includes DBS) Measles Virus Measles isolation/ Reverse Total % of Samples Rubella detection Transcription- number of samples tested for Rubella IgM (+) IgM (swab, urine and Polymerase Chain lab with rubella IgM equiv others) Reaction confirmed results ≤4 No. of No. of cases No. of days No. No. % No. samples samples No. (+) isolates tested tested 100.0 100.0 93.8 89.5 100.0 91.5 100.0 95.5 0.0 99.7 80.6 100.0 100.0 69.2 0.0 93.5
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, M acao SAR Japan Lao People's Democratic Republic M alaysia M ongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Total "-" No data
VIDRL DLS NIPH CCDC PHLC PHL NIID NCLE NPHL NCCD CHL CPHL RITM KCDC NPHL NIHE PI PI IHE FCCDC
12 1 137 46 6 166 109 1 332 82 75 4 370 81 51 12 45 3 22 2 554
0 0 0 2 0 0 0 215 0 0 0 11 0 15 0 0 0 0 0 243
0 13 0 3 16
9 0 0 11 0 70 0 0 2 42 0 15 25 43 0 0 0 0 0 217
9 5 38 0 6 0 2 15 75
8 0 4 2 0 39 0 148 0 7 0 5 6 17 0 0 0 0 236
0 1 136 35 6 1 109 851 82 20 4 371 23 8 12 45 3 0 22 1 729
0 1 0 0 0 0 12 1 0 0 59 4 0 0 2 0 1 80
0.0 0.7 0.0 0.0 0.0 1.4 1.2 0.0 0.0 15.9 17.4 0.0 0.0 4.4 4.5 4.6
0 0 0 0 1 0 0 18 3 0 0 29 5 0 1 0 0 0 57
7
Figure 3. Measles genotype distribution of cases with rash onset in 2016 and 2017, WHO Western Pacific Region
2016
2017
B3 D4 D8 D9 The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved.
D11 G3 H1
Table 7. Measles genotype distribution of cases with rash onset in March 2016 to February 2017, WHO Western Pacific Region 2016 Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas
2017
Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D4 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 2 7 1 8 6 5 1 4 8 1 7 8 14 2 2 2 2 4 4 11 4 2 5 7 1 615 582 2 443 241 131 42 18 2 3 8 22 1 1 2 1 2 2 1 5 13 10 9 1 1 2 7 2 6 6 20 3 1 1 1 2 2 3 1 6 5 2 3 10 16 2 10 2 1 5 2 2 4 6 1 15 15 15 18 7 10 4 2 1 1 3 4 2 2 14 2 1 1 4 14 44 22 10 10 1 1 8 1 5 3 1 1 1 4 1
Sources: Includes all cases reported to the Western Pacific Regional Office by 20 March 2017 and the Measles Nucleotide Surveillance online database (MeaNS).
8
Figure 4. Rubella genotype distribution of cases with rash onset in 2016 and 2017, WHO Western Pacific Region
2016
2017
2B 1E
The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved.
Table 8. Rubella genotype distribution of cases with rash onset in March 2016 to February 2017, WHO Western Pacific Region Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Sources: Includes all cases reported to the Western Pacific Regional Office by 20 March 2017 and the Rubella Nucleotide Surveillance online database (RubeNS).
2016 2017 Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 1 1
26
27
16 5
6 1 4
2
1
1
2
15
1 1
3
2
1
1
1
1 5 1
1 1 1
1 6
9
Table 9A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2016 —2017 Country Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Completeness Timeliness 1 2
2016 Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 92% 100% 100% 100% 100% 100% 100% 2
1
2017 3
1 2
Timeliness 75% 100% 100% 83% 100% 100% 100% 100% 100% 83% 100% 50% 75% 100% 100% 92% 100%
Jan 10 Feb 07 Feb 10 Feb 15 Feb 10 Feb 07 Feb 06 Feb 10 Feb 07 Feb 09 Feb 09 Feb 08 Feb
Feb 09 Mar 06 Mar 10 Mar 11 Mar 09 Mar 07 Mar 09 Mar 10 Mar 09 Mar 07 Mar 07 Mar 08 Mar
Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 50% 0%
Timeliness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 0% 100% 100% 100% 100%
3
10 Feb 08 Feb 09 Feb 14 Feb 94%
09 Mar 09 Mar 10 Mar 14 Mar 94% 94%
100% 100% 100% 100% 94%
92%
94%
94%
National measles surveillance monthly reports from February 2017.
Legend: black = timely report; red = untimely report
Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and
year. 3
China may report to the Regional Office by the 15th (or the next working day) of the following month.
Table 9B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2016 —2017 2016 Country/area 2017 1
Genotype results by source of data Completeness 2 Timeliness 3
Jan
Feb
Completeness 2
Timeliness
3
Measles MeaNS Submission to WPRO 5 0 0 23 2 0 11 0 0 0 4 0 0 1 13 0 0 0 0 0
Rubella Rubens 1 0 0 0 0 0 2 0 0 0 1 0 6 0 0 0 0 0 0 0 Submission to WPRO 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Completeness Timeliness 1 2 3
100% 100% 100% 100% 100% 100% 100% 100% 100% 92% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
100% 100% 100% 100% 100% 100% 100% 100% 83% 67% 100% 33% 92% 100% 100% 92% 100% 92% 92% 92%
03 Feb 04 Feb 10 Feb 03 Feb 09 Feb 07 Feb 06 Feb 10 Feb 08 Feb 10 Feb 09 Feb 13 Feb 21 Feb 10 Feb 08 Feb 07 Feb 10 Feb 07 Feb 07 Feb 14 Feb 100%
06 Mar 02 Mar 10 Mar 06 Mar 07 Mar 08 Mar 09 Mar 10 Mar 09 Mar 06 Mar 07 Mar 10 Mar 08 Mar 10 Mar 09 Mar 07 Mar 08 Mar 07 Mar 07 Mar 14 Mar 100% 100%
100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 50% 50% 100% 100% 100% 100% 100% 100% 100%
18 0 0 23 2 0 1 0 6 0 7 0 0 1 0 0 0 0 0 0
92%
100%
95%
58
59
10
2
National measles laboratory monthly reports from February 2017. Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year. National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.
Legend: black = timely report; red = untimely report
Expanded Programme on Immunization Regional Office for the Western Pacific World Health Organization P.O. Box 2932, 1000 Manila, Philippines Tel. No. (63 2) 5288001 Fax No. (63 2) 5211036, 5260279 Please send your comments and monthly data before the 10th of the month to: WPROEPIdata@who.int More detailed information available in the Regional and country profile of measles elimination
10